# dapagliflozin and metformin hydrochloride

NDC: 67877-619
Generic name: dapagliflozin and metformin hydrochloride
Labeler / Manufacturer: Ascend Laboratories, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, FILM COATED, EXTENDED RELEASE
Routes: ORAL
Marketing started: 20260406

FDA application: ANDA211563

## Active ingredients

- DAPAGLIFLOZIN: 5 mg/1
- METFORMIN HYDROCHLORIDE: 500 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"67877-619"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=67877-619
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=eadcc3ef-f5c2-4a56-a6aa-12909844144e